Takatsuki, Japan

Dai Motoda

USPTO Granted Patents = 4 

 

 

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Takatsuki, JP (2011 - 2014)
  • Osaka, JP (2020)

Company Filing History:


Years Active: 2011-2020

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dai Motoda: Innovator in Pharmaceutical Compounds

Introduction

Dai Motoda is a notable inventor based in Takatsuki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target various health conditions. With a total of 4 patents to his name, Motoda's work is recognized for its potential impact on medical treatments.

Latest Patents

Motoda's latest patents include a nitrogen-containing heterocyclic amide compound, which has demonstrated PDHK inhibitory activity. This compound is useful for treating or preventing a range of conditions, including diabetes, insulin resistance syndrome, and various complications associated with metabolic disorders. Another significant patent is for a pyrazole compound that exhibits SGLT1 inhibitory activity, which also holds promise for pharmaceutical applications.

Career Highlights

Dai Motoda is currently associated with Japan Tobacco Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a focus on developing compounds that can address critical health issues, showcasing his commitment to advancing medical science.

Collaborations

Motoda has collaborated with notable colleagues, including Kazuhito Ueyama and Yosuke Ogoshi. These partnerships have likely contributed to the success and breadth of his research endeavors.

Conclusion

Dai Motoda's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a dedication to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…